• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . Risk factors of pneumothorax and pneumomediastinum in COVID-19: a matched case-control study

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2023 Mar 7;23(1):137.
doi: 10.1186/s12879-023-08104-3.
Risk factors of pneumothorax and pneumomediastinum in COVID-19: a matched case-control study


Se Ju Lee[SUP] 1 2 [/SUP], Jinnam Kim[SUP] 1 [/SUP], Ki Hyun Lee[SUP] 1 [/SUP], Jung Ah Lee[SUP] 1 [/SUP], Chang Hyup Kim[SUP] 1 [/SUP], Su Hwan Lee[SUP] 3 [/SUP], Byung Jo Park[SUP] 4 [/SUP], Jung Ho Kim[SUP] 1 [/SUP], Jin Young Ahn[SUP] 1 [/SUP], Su Jin Jeong[SUP] 1 [/SUP], Nam Su Ku[SUP] 1 [/SUP], Joon-Sup Yeom[SUP] 1 [/SUP], Jun Yong Choi[SUP] 5 [/SUP]



Affiliations

Abstract

Background: During the novel coronavirus disease-2019 pandemic, a considerable number of pneumothorax (PNX)/pneumomediastinum (PNM) associated with COVID-19 have been reported, and the incidence is higher in critically ill patients. Despite using a protective ventilation strategy, PNX/PNM still occurs in patients on invasive mechanical ventilation (IMV). This matched case-control study aims to identify the risk factors and clinical characteristics of PNX/PNM in COVID-19.
Methods: This retrospective study enrolled adult patients with COVID-19, admitted to a critical care unit from March 1, 2020, to January 31, 2022. COVID-19 patients with PNX/PNM were compared, in a 1-2 ratio, to COVID-19 patients without PNX/PNM, matched for age, gender, and worst National Institute of Allergy and Infectious Diseases ordinal scale. Conditional logistic regression analysis was performed to assess the risk factors for PNX/PNM in COVID-19.
Results: 427 patients with COVID-19 were admitted during the period, and 24 patients were diagnosed with PNX/PNM. Body mass index (BMI) was significantly lower in the case group (22.8 kg/m[SUP]2[/SUP] and 24.7 kg/m[SUP]2[/SUP]; P = 0.048). BMI was statistically significant risk factor for PNX/PNM in univariate conditional logistic regression analysis [odds ratio (OR), 0.85; confidence interval (CI), 0.72-0.996; P = 0.044]. For patients on IMV support, univariate conditional logistic regression analysis showed the statistical significance of the duration from symptom onset to intubation (OR, 1.14; CI, 1.006-1.293; P = 0.041).
Conclusions: Higher BMI tended to show a protective effect against PNX/PNM due to COVID-19 and delayed application of IMV might be a contributive factor for this complication.

Keywords: COVID-19; Pneumomediastinum; Pneumothorax; Risk factors.
 
Back
Top Bottom